Teva Pharmaceutical Industries News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

10.12.13	Teva Appoints Amir Elstein To Succeed Moshe Many As Vice Chairman - Quick Facts (RTTNews)
10.12.13	Teva Sees 2014 Earnings Below View If Copaxone Competitors Launched (RTTNews)
10.12.13	Teva Sees Fiscal 2014 EPS Of $4.20-$4.50 In Generic Copaxone Scenario (RTTNews)
04.12.13	Teva And Takeda Announce Deal For Glatiramer Acetate For MS Treatment In Japan (RTTNews)
27.11.13	Teva Pharma Reports Addl. Regulatory Exclusivity For TREANDA For Injection (RTTNews)
26.11.13	Echo Sounds Louder, PBMD Gets Prime Attention, Xmas Coming Early For CYCC (RTTNews)
25.11.13	Teva To Investigate 'unauthorized' Publication (RTTNews)
11.11.13	Teva To Pay State Of Israel $718 Mln. In Taxes (RTTNews)
04.11.13	Active Biotech's Partner Teva Begins Further Study In Multiple Sclerosis (RTTNews)
31.10.13	Teva Pharma Swings To Profit In Q3, Results Beat View (RTTNews)
31.10.13	Teva Q3 Results Beat Estimates; Updates FY13 Outlook - Quick Facts (RTTNews)
31.10.13	Earnings Watch For October 31 (CAH, CLX, COP, XOM, MA, MGM, TWC) (RTTNews)
30.10.13	Teva's President & CEO Jeremy Levin Resigns; Names Interim CEO - Update (RTTNews)
30.10.13	Teva President & CEO Jeremy Levin To Step Down - Quick Facts (RTTNews)
16.10.13	Awareness Programs, Restructuring Efforts, Conference Calls, Marketing Authorization Withdrawal and Clinical Trial Commencement - Research Report on Lilly, Teva, Elan, Zoetis, and Boston Scientific (PR Newswire)
14.10.13	Teva Receives FDA Approval For Generic Version Of TOBI - Quick Facts (RTTNews)
10.10.13	Pre-market Movers For Oct 10 (AAPL, SIRI, CAFI, TEVA, PVR, IGTE, CTXS, RT) (RTTNews)
10.10.13	Teva To Cut 5000 Jobs, Sees $2 Bln In Annual Cost Savings By 2017 (RTTNews)
10.10.13	Teva To Cut 5,000 Jobs Globally - Quick Facts (RTTNews)
04.10.13	Teva Presents Additional Analyses Of Late-stage Allegro And Bravo Studies (RTTNews)
03.10.13	Teva Reports Further Results From Long-term, Open-label Extension Study Of GA (RTTNews)
30.09.13	Product Launches, Clinical Study Results, Historical Trials, Joint Lawsuits and Milestone Patient Enrollment - Research Report on Teva, Pacira, Novo Nordisk, Forest, and Amarin (PR Newswire)
27.09.13	Under AAAResearchReports.com Microscope: Zoetis Inc., Teva Pharma Industries Ltd, Covidien PLC, and Valeant Pharma Intl. Inc. (PR Newswire)
26.09.13	FDA Approvals, New Appointments, Positive Litigation Outcomes and Partnerships - Research Report on Edwards Lifesciences, Illumina, Teva, Alere, and Dr. Reddy's (PR Newswire)
24.09.13	Teva Announces Quartette™ (levonorgestrel/ethinyl estradiol and ethinyl estradiol) Tablets Now Available for the Prevention of Pregnancy in the United States (PR Newswire)
24.09.13	Teva Pharma Launches Generic ADENOSCAN In US - Quick Facts (RTTNews)
23.09.13	Teva Wins Azilect Patent Dispute Against Mylan - Quick Facts (RTTNews)
19.09.13	Legal Actions, Quarterly Dividends, Collaborations, and New Appointments - Research Report on Johnson & Johnson, Zoetis, Abbott, Teva Pharmaceuticals, and Baxter (PR Newswire)
17.09.13	Teva's TREANDA Injection Gets FDA Approval - Quick Facts (RTTNews)
16.09.13	Teva, Cancer Research Technology Sign R&D Alliance Agreement - Quick Facts (RTTNews)
29.08.13	AEZS Shifts Listing, AUXL Gets New Decision Date, Teva Hangs Up On RNN Deal (RTTNews)
28.08.13	Rexahn Pharma: Teva Decides Not To Exercise Its Option To License RX-3117 (RTTNews)
21.08.13	Technical Study: Zoetis Inc., Teva Pharma Industries Ltd, Covidien plc, and Valeant Pharma Intl. Inc. (PR Newswire)
12.08.13	Teva Pharma, Perrigo Announce U.S. Launch Of Generic Temozolomide - Quick Facts (RTTNews)
12.08.13	Financial Results Release, Management Changes, and Newly Issued Permits - Research Report on Valeant, Teva, Endo, Array, and Sequenom (PR Newswire)
09.08.13	Critical Alerts For Amazon, Teva Pharmaceuticals, Charles Schwab, VMware, and Level 3 Communications Released By InvestorsObserver (PR Newswire)
06.08.13	Strong Sales, Diversified Portfolio, and R&D Progress Boost Growth - Research Report on Teva, Auxilium, Nektar, Anika, and Vical (PR Newswire)
01.08.13	Teva Q2 Profit Meets Estimates, While Mylan Profit Beats View; But Revenues Miss (RTTNews)
01.08.13	Teva Q2 Adj. Profit Matches View, But Revenues Miss - Quick Facts (RTTNews)
01.08.13	Earnings Watch For August 1 (CAH, PG, KRFT, COP, XOM, LNKD) (RTTNews)
29.07.13	English Appeal Court Rules In Favor Of Teva In Copaxone Patent Case (RTTNews)
25.07.13	Teva, Lonza To Discontinue Biosimilars Collaboration (RTTNews)
23.07.13	FDA Designations to Development Programs and Quarterly Financial Results Schedules - Research Report on Valeant, Elan, Alkermes, Teva and Gilead (PR Newswire)
18.07.13	Teva Found On Summary Judgment To Infringe Mylan Patent For Perforomist (RTTNews)
18.03.10	Teva to Acquire ratiopharm (Businesswire)
17.03.10	Teva Provides Update on Generic Temodar® (Businesswire)
22.01.10	Court of Appeals Affirms Favorable Decision Regarding Generic Prevacid® SoluTab (Businesswire)
07.01.10	Teva Announces Settlement Agreements with AstraZeneca Regarding Generic Prilosec® and Nexium® (Businesswire)
10.09.09	COPAXONE® Significantly Reduced Disease Severity in Long-Term Treated Multiple Sclerosis Patients (Businesswire)
08.09.09	New Teva Data Highlights Advances in MS Treatment Research (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	31.13	2.91 %	K V
Geberit	505.80	2.47 %	K V
ABB	50.70	2.09 %	K V
Holcim	87.22	2.06 %	K V
CieFinRichemont	163.75	1.21 %	K V
Swisscom	512.50	0.10 %	K V
Sonova Hldg	302.60	-0.40 %	K V
Logitech Intl	79.70	-0.62 %	K V
Roche Hldg G	265.40	-1.19 %	K V
Novartis	89.32	-1.40 %	K V

mehr

17.01.25		NYSE-Handel: Dow Jones legt zum Handelsende zu
17.01.25		Zuversicht in New York: S&P 500 mit Zuschlägen
17.01.25		Starker Wochentag in New York: Dow Jones auf grünem Terrain
17.01.25		Gewinne in New York: Dow Jones im Plus
17.01.25		Aufschläge in New York: S&P 500-Anleger greifen zu
17.01.25		SMI-Handel aktuell: SMI zum Handelsende stärker
17.01.25		Börse Zürich: SLI zeigt sich schlussendlich fester
17.01.25		Gute Stimmung in Europa: STOXX 50 notiert zum Ende des Freitagshandels im Plus

17.01.25

NYSE-Handel: Dow Jones legt zum Handelsende zu

17.01.25

Zuversicht in New York: S&P 500 mit Zuschlägen

17.01.25

Starker Wochentag in New York: Dow Jones auf grünem Terrain

17.01.25

Gewinne in New York: Dow Jones im Plus

17.01.25

Aufschläge in New York: S&P 500-Anleger greifen zu

17.01.25

SMI-Handel aktuell: SMI zum Handelsende stärker